Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China
BackgroundPlasma beta-amyloid (Aβ) are important biomarkers for Alzheimer’s disease and cognitive impairment (CI), but results are controversial. It remains unclear whether hypertension modulates their relationship. This cross-sectional study investigates whether hypertension moderates the relations...
Saved in:
Main Authors: | Ziyu Liu, Yaoli He, Simeng Cui, Liangjun Dang, Binyan Zhang, Jin Wang, Wenhui Lu, Kang Huo, Yu Jiang, Chen Chen, Ling Gao, Shan Wei, Yi Zhao, Ningwei Hu, Jingyi Wang, Hong Lv, Qiumin Qu, Suhang Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2025.1532676/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01) -
Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01) -
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01) -
Thioflavin-T: application as a neuronal body and nucleolar stain and the blue light photo enhancement effect
by: Jin-Hong Min, et al.
Published: (2024-10-01) -
Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)